SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-100169
Filing Date
2020-08-28
Accepted
2020-08-28 16:06:13
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 tm2029497-1_s3.htm S-3 373482
2 EXHIBIT 4.3 tm2029497d2_ex4-3.htm EX-4.3 355362
3 EXHIBIT 5.1 tm2029497d2_ex5-1.htm EX-5.1 18825
4 EXHIBIT 23.1 tm2029497d2_ex23-1.htm EX-23.1 2573
5 EXHIBIT 23.2 tm2029497d2_ex23-2.htm EX-23.2 2415
6 GRAPHIC lg_arbutusbiopharma-4c.jpg GRAPHIC 774554
7 GRAPHIC tm2029497d2_ex5-1img01.jpg GRAPHIC 3689
8 GRAPHIC tm2029497d2_ex5-1img02.jpg GRAPHIC 8896
  Complete submission text file 0001104659-20-100169.txt   1838511
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-248467 | Film No.: 201147914
SIC: 2834 Pharmaceutical Preparations